J&J Vows To Fix Compliance, Quality Issues In Investor Deal
In a settlement that would lay to rest a slew of investor suits against Johnson & Johnson, the drug giant on Wednesday agreed to adopt rigorous internal controls to tighten oversight...To view the full article, register now.
Already a subscriber? Click here to view full article